Pathophysiology of mitochondrial cell death control

Cellular and Molecular Life Sciences

Volumn 56, Issue 11-12, 1999, Pages 971-976

  Vieira, H L A ^a   Kroemer, G ^a  

^a CNRS   (France)

Author keywords

Apoptosis; Necrosis; Permeability transition

Indexed keywords

MEMBRANE PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; CANCER; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE DEGENERATION; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; INTRACELLULAR MEMBRANES; ION CHANNELS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PERMEABILITY; SOLUBILITY;

EID: 0033400223     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050486     Document Type: Review

References (42)

1. 1 Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281: 1309 1312
2. 2 Zamzami N., Susin S. A., Marchetti P., Hirsch T., Gómez-Monterrey I., Castedo M. et al. (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183: 1533-1544
3. 3 Liu X. S., Kim C. N., Yang J., Jemmerson R. and Wang X. (1996) Induction of apoptolic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 86: 147 157
4. 4 Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A. et al. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184: 1331 1342
5. 5 Mancini M., Nicholson D. W., Roy S., Thornberry N. A., Peterson E. P., Casciola-Rosen L. A. et al. (1998) The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140: 1485 1495
6. 6 Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Larochette N., Alzari P. M. et al. (1999) Mitochondrial release of caspases-2 and -9 during the apoptotic process. J. Exp. Med. 189: 381 394
7. 7 Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor (AIF). Nature 397: 441 446
8. 8 Samali A., Cai J., Zhivotovsky B., Jones D. P. and Orrenius S. (1999) Presence of a pre-apoptotic complex of pro-caspase-3, hsp60, and hsp10 in the mitochondrial fraction of Jurkat cells. EMBO J. 18: 2040-2048
9. 9 Xanthoudakis S., Roy S., Rasper D., Hennessey T., Aubin Y., Cassady R. et al. (1999) Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J. 18: 2049 2056
10. 10 Saksela M., Lapatto R. and Raivio K. O. (1999) Irreversible conversion of xanthine dehydrogenase into xanthine oxidase by a mitochondrial protease. FEBS Lett. 443: 117-120
11. 11 Xiang J., Chao D. T. and Korsmeyer S. J. (1996) Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93: 14559 14563
12. 12 Hirsch T., Marchetti P., Susin S. A., Dallaporta B., Zamzami N., Marzo I. et al. (1997) The apoptosis-necrosis paradox: apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15: 1573 1582
13. 13 Leist M., Single B., Castoldi A. F., Kühnle S. and Nicotera P. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185: 1481 1486
14. 14 Heiden M. G. vander, Chandal N. S., Williamson E. K., Schumacker P. T. and Thompson C. B. (1997) Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627 637
15. 15 Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S. et al. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144: 891 901
16. 16 Shimizu S., Narita M. and Tsujimoto Y. (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483 487
17. 17 Crompton M., Virji S. and Ward J. M. (1998) Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258: 729 735
18. 18 Woodfield K., Ruck A., Brdiczka D. and Halestrap A. P. (1998) Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 336: 287 290
19. 19 Marzo I., Brenner C., Zamzami N., Susin S. A., Beutner G., Brdiczka D. et al. (1998) The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2 related proteins. J. Exp. Med. 187: 1261-1271
20. 20 Marzo I., Brenner C., Zamzami N., Jürgensmeier J., Susin S. A., Vieira H. L. A. et al. (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027 2031
21. 21 Narita M., Shimizu S., Ito T., Chittenden T., Lutz R. J., Matsuda H. et al. (1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 95: 14681 14686
22. 22 Jürgensmeier J. M., Xie Z., Deveraux Q., Ellerby L., Bredesen D. and Reed J. C. (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95: 4997-5002
23. 23 Kroemer G., Dallaporta B. and Resche-Rigon M. (1998) The mitochondrial death life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60: 619 642
24. 24 Heiskanen K. M., Bhat M. B., Wang H. W., Ma J. J. and Nieminen A. L. (1999) Mitochondrial depopolarization accompanies cytochrome c release during apoptosis in PC6 cells. J. Biol. Chem. 274: 5654 5658
25. 25 Wallace D. C. (1999) Mitochondrial diseases in mouse and man. Science 1475: 1482 1488
26. 26 Cassarino D. S., Swerdlow R. H., Parks J. K., Parker W. D. and Bennett J. P. (1998) Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem. Biophys. Res. Commun. 248: 168 173
27. 27 Cassarino D. S. and Bennett J. P. (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative athology, protective nuclear responses, and cell death in neurodegeneralion. Brain Res. Rev. 29: 1 25
28. 28 Radisky D. C., Babcock M. C. and Kaplan J. (1999) The yeast frataxin homologue mediates mitochondrial iron efflux evidence for a mitochondrial iron cycle. J. Biol. Chem. 274: 4497 4499
29. 29 Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P. et al. (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93: 973 983
30. 30 Guo Q., Fu W. M., Sopher B. L., Miller M. W., Ware C. B., Martin G. M. et al. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-Imutant knock-in mice. Nat. Med. 5: 101 106
31. 31 Zoratti M. and Szabò I. (1995) The mitochondrial permeability transition. Biochem. Biophys. Acta Rev. Biomembranes 1241: 139 176
32. 32 Friberg H., Connern C., Halestrap A. P. and Wieloch T. (1999) Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J. Neurochem. 72: 2488 2497
33. 33 Klivenyi P., Ferrante R. J., Matthews R. T., Bogdnaow M. B., Klein A. L. et al. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5: 347 350
34. 34 Tanabe H., Eguchi Y., Kamada S., Martinou J. C. and Tsujimoto Y. (1997) Susceptibility of cerebellar granule neurons derived from Bcl-2-deficient and transgenic mice to cell death. Eur. J. Neurosci. 9: 848 856
35. 35 Friberg H., Ferrand Drake M., Bengtsson F., Halestrap A. P. and Wieloch T. (1998) Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18: 5151-5159
36. 36 Okonkwo D. O., Buki A., Siman R. and Povlishock J. T. (1999) Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10: 353 358
37. 37 Dang C. V. and Semenza G. L. (1999) Oncogenic alterations of metabolism. Trends Biochem. Sci. 24: 68 72
38. 38 Katabi M. M., Chan H. L. B., Karp S. and Batist G. (1999) Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells. Hum. Gene Ther. 10: 155-164
39. 39 Barrath P., Albert-Fournier B., Luciakova K. and Nelson B. D. (1999) Characterization of a silencer clement and purification of a silencer protein that negatively regulates the human adenine nucleotidc translocator 2 promoter. J. Biol. Chem. 274: 3378 3384
40. 40 Kanazawa A., Tanaka A., Iwata S., Satoh S., Hatano E., Shinohara H. et al. (1998) The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death. J. Surg. Res. 80: 229 235
41. 41 Kroemer G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3: 614 620
42. 42 Van der Heiden M., Chandel N. S., Schumacker P. T. and Thompson C. B. (1999) Bcl-XL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP ADP exchange. Mol. Cell 3: 159 167